Abstract
Since 1992, the study of biological functions of HIV-1 gp41 has made great progress. Experimental evidence from several research groups demonstrated that gp41 has a putative cellular receptor. A recombinant soluble gp41 (aa539–684) and gp41 immunosuppressive peptide (aa583–599) could bind to human B lymphocytes and monocytes, but weakly bind to T lymphocytes. It was found that gp41 contains two cellular binding sites (aa583–599 and 641–675). GP41 could selectively inhibit cell proliferation of human T, B lymphocytes and monocytes, enhance human MHC class I, II and ICAM-1 molecule expression on cell surface. Gp41 binding proteins and a monoclonal antibody against the first binding site could inhibit this modulation effect. Amino acid sequence homology exists between gp41 and human type I interferons, and the homologous region is located in the first binding site on gp41 and in the receptor binding site on type I interferons. Studies in other groups indicate that both binding sites in gp41 may be associated with HIV infection of cells. Peptides containing two binding sites could respectively inhibit HIV infection of cells. A monoclonal antibody recognizing the second binding site could neutralize lab-strains and recently separated strains of HIV-1. Besides, antibodies against two regions (homologous with gp41 binding sites) of SIV transmembrane protein gp32 could protect macaques from SIV infection. These results suggest that the study of gp41 binding sites and cellular receptor could contribute to understanding the mechanism of HIV infection and to developing HIV vaccine and anti-HIV drugs.
Similar content being viewed by others
References
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R.,et al., The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus,Nature, 1984, 312: 763.
Feng, Y., Broder, C. C., Kennedy, P. E.et al., HIV-1 entry cofactor; functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor,Science, 1996, 272: 872.
Dragic, T., Litwin, V., Allaway, G. P.et al., HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5,Nature, 1996, 381: 667.
Binley, J., Moore, J. P., The viral mousetrap,Nature, 1997, 387: 346.
Chen, Y. H., Ebenbichler, C., Vornhagen, R.et al., HIV-1 gp41 contains two sites for interaction with several proteins on the helper T-lymphoid cell line, H9,AIDS, 1992, 6: 533.
Chen, Y. H., Böck, G., Vornhagen, R.et al., HIV-1 gp41 binds to several proteins on the human B cell line,Raji. Mol. Immunol., 1993, 30: 1159.
Chen, Y. H., Böck, G., Vornhagen, R.et al., The human monocytes cell line U937 by proteins of 37, 45, 49, 62 and 92 kD binds HIV-1 gp41,Immunol. Lett., 1993, 37: 41.
Chen, Y. H., Böck, G., Vornhagen, R.et al., HIV-1 gp41 binding to human peripheral blood mononuclear cells occurs preferentially to B lymphocytes and monocytes,Immunobiology, 1993, 188: 323.
Chen, Y. H., Christiansen, A., Böck, G.et al., HIV-2 transmembrane protein gp36 like HIV-1 gp41 binds to human lymphocytes and monocytes,AIDS, 1995, 9: 1193.
Chen, Y. H., Christiansen, A., Dierich, M. P., HIV-1 gp41 binding to human T and B-lymphocytes and monocytes is modulated by phorbol myristate acetate,Immunol. Lett., 1996, 50: 161.
Chen, Y. H., Dierich, M. P., Identification of a second site in HIV-1 gp41 mediating binding to cells,Immunol. Lett., 1996, 52: 153.
Cheingsong-Popov, R., Panagiotidi, C., Caun, K.et al., Antibodies to a putative HIV gp41 immunosuppressive peptide, pHIVIS (583–599), do not correlate significantly with outcome in HIV infection,AIDS, 1990, 4: 251.
Henderson, L. A., Qureshi, M. N., A peptide inhibitor of human immunodeficiency virus infection binds to novel human cell surface polypeptides,J. Biol. Chem., 1993, 268: 15291.
Denner, J., Vogel, T., Norlet, S.et al., The immunosuppressive (ISU-) peptide of HIV-1: Binding proteins on lymphocytes detected by different methods,J. Can. Res. Clin. Oncol., 1994, 121(S1): S35(11/128).
Sattentau, Q. J., Moore, J. P., Conformational changes induced in human immunodeficiency virus envelope glycoprotein by soluble CD4 binding,J. Exp. Med., 1991, 174: 407.
Muster, T., Steindl, F., Purtscher, M.et al., A conserved neutralizing epitope on gp41 of human immunodeficiency virus type I,J. Virol., 1993, 67: 6642.
Purtscher, M., Trkola, A., Gruber, G.et al., A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1,AIDS Res. Human Retroviruses, 1994, 10: 1651.
Chen, Y. H., Böck, G., Vornhagen, R.et al., HIV-1 gp41 binding proteins and antibodies to gp41 could inhibit enhancement of human Raji cell MHC class I and II antigen expression by gp41,Mol. Immunol., 1994, 31: 977.
Ebenbichler, C., Roder, C., Vornhagen, R.et al., Cell surface proteins binding to recombinant soluble HIV-1 and HIV-2 transmembrane proteins,AIDS, 1993, 7: 489.
Chowdhury, I. H., Koyanagi, Y., Kobayashi, S.et at., The phorbol ester TPA strongly inhibits HIV-1-induced syncytia formation but enhances virus production: possible involvement of protein kinase C pathway,Virology, 1990, 176: 126.
Chen, Y. H., Opitz, S., Bock, G.et al., Enhancement of HIV-1 gp41 binding to Raji cells by PWM, LPS, interferon γ and interleukin 6,Mol. Immunol., 1993, 30: 1583.
Chen, Y. H., Speth, C., Wu, W.et al., Antigenic characterization of HIV-1 gp41 binding proteins,Immunology Letters, 1997/1998, 198: 333.
Chen, Y. H., Christiansen, A., Dierich, M. P., HIV-1 gp41 selectively inhibits spontaneous cell proliferation of human cell lines and mitogen- and recall antigen-induced lymphocyte proliferation,Immunol. Lett., 1995, 48: 39.
Denner, J., Norlet, S., Kurth, R., The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients,AIDS, 1994, 8: 1063.
Cianciolo, G. J., Kipnis, R. J., Snyderman, R., Similarity between pl5E of murine and feline leukemia viruses and p21 of HTLV,Nature, 1984, 311: 515.
Ruegg, C. L., Strand, M., Inhibition of protein kinase C and anti-CD3-induced Ca2+ influx in Jurkat T cells by a synthetic peptide with sequence identity to HIV-1 gp41,J. Immunol., 1990, 144: 3928.
Ruegg, C. L., Strand, M., A synthetic peptide with sequence identity tq the membrane protein gp41 of HIV-1 inhibits distinct lymphocyte activation pathways dependent on protein kinase C and intracellular calcium influx,Cellular Immunol., 1991, 1137: 1.
Chen, Y. H., Böck, G., Vornhagen, R.et al., HIV-1 gp41 like interferons enhances MHC class I and ICAM-1 expression on H9 and U937 cells,Intern. Arch. Allergy Immunol., 1994, 104: 227.
Jiang, S., Lin, K., Strick, N., HIV-1 inhibition by a peptide,Nature, 1993, 365: 113.
Shafferman, A., Jahrling, P. B., Benveniste, R. E.et al., Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences,Proc. Natl. Acad. Sci. USA, 1991, 88: 7126.
Lewis, M. G., Elkins, W. R., McCutchan, F. E.et al., Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection,Vaccine, 1993, 11: 1347.
Chen, Y. H., Xiao, Y., Wu, W.et al., The immunosuppressive peptide of HIV-1 gp41 like human type I interferons up-regulates MHC class I expression on H9 and U937 cells,Immunol. Lett., 1997, 59: 93.
Feng, Y., Broder, C. C., Kennedy, P. E.et al., HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor,Science, 1996, 272: 872.
Author information
Authors and Affiliations
About this article
Cite this article
Chen, Y., Dierich, M.P. Biological function of H1V-1 transmembrane protein gp41. Chin. Sci. Bull. 43, 1630–1635 (1998). https://doi.org/10.1007/BF02883408
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02883408